Chaves, K. C. B.; Peron, Jean Pierre Schatzmann 
; Chammas, R.; Turaça, L. T.; Pesquero, J. B.; Braga, M. S.; Foguer, K.; Schor, N.; Bellini, M. H.
Source: Cancer Gene Therapy. Unidade: FM
Subjects: IMUNOTERAPIA, DNA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, K. C. B. et al. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Cancer Gene Therapy, v. 19, n. 8, p. 558-565, 2012Tradução . . Disponível em: https://doi.org/10.1038/cgt.2012.32. Acesso em: 30 abr. 2024.APA
Chaves, K. C. B., Peron, J. P. S., Chammas, R., Turaça, L. T., Pesquero, J. B., Braga, M. S., et al. (2012). Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Cancer Gene Therapy, 19( 8), 558-565. doi:10.1038/cgt.2012.32NLM
Chaves KCB, Peron JPS, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model [Internet]. Cancer Gene Therapy. 2012 ; 19( 8): 558-565.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/cgt.2012.32Vancouver
Chaves KCB, Peron JPS, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model [Internet]. Cancer Gene Therapy. 2012 ; 19( 8): 558-565.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/cgt.2012.32
